Dr. Kim shares his clinical experience with amivantamab in real-world practice for EGFR+ NSCLC, discussing both the benefits and challenges of incorporating it into treatment protocols.
Video content above is prompted by the following:
Stay up to date on recent advances in the multidisciplinary approach to cancer.